Seqmatic, LLC

Fremont, CA

UEI
T8LRGLKLMMT3
CAGE
6SL88
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
48383 Fremont Blvd #120, Fremont, CA 94538, USA
Website
seqmatic.com
Founded
2012
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $429,733
FY2025 $452,395
FY2024 $662,535
FY2023 $553,213

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Commerce $208,978
2 Department of Agriculture $198,985
3 Department of Health and Human Services $21,770

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California, provides next-generation sequencing and genomic analysis services to federal civilian agencies as a prime contractor (100% of recent awards), competing across both set-aside and full-and-open procurement vehicles. The company operates as a limited liability partnership under primary NAICS 541380 (Testing Laboratories and Services) and 541714 (Research and Development in Biotechnology), with operational capacity in Fremont, St. Paul, Auburn, and Silver Spring.

Seqmatic's customer concentration is dominated by a single anchor award that comprises 99% of its combined potential value: a $149.17 million multiple-award indefinite-delivery contract with the National Cancer Institute, awarded January 13, 2025, running through January 12, 2030, for Genome Characterization Center services. This IDIQ acquires whole exome sequencing, whole-genome sequencing, epigenetic characterization, and single-cell/single-nuclei sequencing to support NCI cancer genomics research, with all work performed as prime with no subcontract exposure. Beyond this anchor, Seqmatic's portfolio spreads across nineteen additional federal agencies. NOAA (11 awards, $721 thousand combined potential value) leads by count, followed by USDA Agricultural Research Service regional offices in the Northeast and other areas (16 awards combined, $792 thousand), and the National Institute of Diabetes and Digestive and Kidney Diseases (6 awards, $142 thousand). The top five customers by count account for 60% of recent awards; the top five by potential value account for 99%, reflecting extreme concentration in the NCI IDIQ.

Seqmatic's recent award activity shows a ramp-up through 2024 (one award in 2022 to twelve in 2024) followed by a modest decline to eight awards year-to-date in 2026. Ten awards carrying combined potential value of $610 thousand reach ultimate completion within the next twenty-four months and face recompete. The company's capability portfolio centers on high-throughput DNA and RNA sequencing, whole-genome and whole-exome sequencing, epigenetic analysis, single-cell and single-nuclei sequencing, and downstream bioinformatics. Representative work outside the NCI IDIQ includes a $196.6 thousand Total Small Business purchase order from NOAA's Southwest Fisheries Science Center for whole genome sequencing of marine samples (September 2026), a $129.8 thousand Total Small Business order from USDA Agricultural Research Service for cotton DNA sequencing supporting the NP301 Plant Genetic Resources program (April 2026), a $141.5 thousand Total Small Business award from the National Institute on Drug Abuse for whole genome sequencing of 325 drug-abuse-research samples (September 2025), a $135 thousand Total Small Business three-year NOAA order for next-generation DNA genome sequencing services across marine research (July 2024), and a $167.2 thousand CDC purchase order for SARS-CoV-2 next-generation sequencing supporting infectious disease monitoring (September 2023).

Seqmatic competes across both Total Small Business set-asides and full-and-open competitions; 28 of 55 awards carry Total Small Business designations, while 27 carry no set-aside designation. Set-aside work recurs predominantly in USDA agricultural genomics contracts and NOAA fisheries and marine research procurements; full-and-open work anchors the NCI IDIQ and appears across NIH institutes (NIDA, NIDDK, NIA, NIAID), FDA, CDC, VA, USGS, and Army DEVCOM. Combined obligation across all awards stands at $2.5 million (2% of combined potential value), indicating a portfolio heavily weighted toward ceiling values and future task orders rather than expended dollars to date.

SBA capabilities narrative

SeqMatic is a San Francisco Bay Area based Illumina, 10X Genomics and Parse Biosciences Certified Service Provider (CSP) of Next Generation Sequencing (NGS) services. We offer comprehensive NGS and other omics services (spatial, histopathology, epigenetics, proteomics) with unparalleled customer service and fast turnaround time. Our scientists specialize in tailoring each project experiments to satisfy specific needs with expert and friendly service.

Quick answers

Is Seqmatic, LLC registered in SAM.gov?

Yes. Seqmatic, LLC's SAM.gov registration is active through May 6, 2027.

Which contract vehicles does Seqmatic, LLC hold?

Seqmatic, LLC holds a place on 1 federal contract vehicle: NCI Genomic Characterization Centers.

How much has Seqmatic, LLC received in federal contracts?

Federal contracts obligated $452,395 to Seqmatic, LLC in fiscal year 2025 and $2,097,876 in fiscal years 2023 through 2027.

How does Seqmatic, LLC rank among federal contractors?

Seqmatic, LLC ranked #43 in PSC B504, #70 in PSC B516 and #97 in PSC B529 in FY2025.

What is Seqmatic, LLC's most recent federal award?

Seqmatic, LLC's most recent federal contract award is Whole genome sequencing services for the national marine fisheries service (nmfs) southwest fisheries science center… (1305M326P0416), from National Oceanic and Atmospheric Administration, on September 30, 2026.

On GovTribe

See Seqmatic, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors